Chem. J. Chinese Universities ›› 2017, Vol. 38 ›› Issue (7): 1216.doi: 10.7503/cjcu20170007

• Physical Chemistry • Previous Articles     Next Articles

Molecular Dynamics Simulation Study on the Binding Modes of Angiotensin-converting Enzyme with Inhibitory Peptides

WANG Song1, GUAN Shanshan1,2, WAN Yongfeng1, SHAN Yaming2, ZHANG Hao1,*()   

  1. 1. Laboratory of Theoretical and Computational Chemistry, Institute of Theoretical Chemistry,Jilin University, Changchun 130061, China
    2. National Engineering Laboratory For AIDS Vaccine, School of Life Science,Jilin University, Changchun 130012, China
  • Received:2017-01-05 Online:2017-07-10 Published:2017-06-20
  • Contact: ZHANG Hao E-mail:stringbell@jlu.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(No.21443008), the 13th Five-Year Plan of Jilin Provincial Department of Education, China(Nos.2016406, 2016408), the Project of Xuzhou Mapeptide Biotechnology Co, Ltd Science and Technology, China(Nos.2016220101000815, 3R2173651449) and the Project of the Graduate Innovation Fund of Jilin University, China(No.2016008)

Abstract:

Binding modes of C-domain of Angiotensin-converting enzyme(ACE) and two peptides RIGLF and AHEPVK which had competitive inhibited potency against ACE, C-domain-RIGLF and C-domain-AHEPVK were investigated with molecular docking, molecular dynamics simulation, and binding free energy, calculation. The calculation results indicate that vital binding residues in C-domain-RIGLF are His353, Asp377, Asp453, Phe457, His513, Tyr523 and Phe527, while key residues in C-domain-AHEPVK are Gln281, His353, Ser355, Glu384, Lys511, His513 and Tyr523. The binding ability between C-domain-RIGLF and C-domain-AHEPVK were compared via MM-PBSA calculation. The calculated results indicate that AHEPVK binds C-domain more easily than RIGLF. The result is consistent with experimental data. The results have academic guidance meaning for exploring the mechanism of how foodborne peptide inhibitors bind to ACE and this work provides the clues for novel medicines design which are mainly aimed at ACE.

Key words: Angiotensin-converting enzyme, Inhibitory peptide, Molecular docking, Molecular dynamics simulation, Free energy calculation

CLC Number: 

TrendMD: